Volume 88 Issue 16 | p. 19 | Concentrates
Issue Date: April 19, 2010

Sanofi Pasteur, Navy Combat Diarrhea

Department: Business
Keywords: vaccines, partnership

Sanofi Pasteur, the vaccines division of Sanofi-Aventis, will partner with the U.S. Naval Medical Research Center to develop a new bacterial vaccine against enterotoxigenic Escherichia coli (ETEC), a bacterium that causes nearly 400,000 childhood deaths in the developing world and is well-known as the cause of traveler's diarrhea. Under the terms of the four-year research pact, NMRC has licensed two ETEC adhesion vaccine technologies to Sanofi Pasteur, including one with a . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society